US2006269539A1PendingUtilityA1

Asp2

54
Individually held — no corporate assignee on recordPriority: Jan 28, 1997Filed: Jun 28, 2006Published: Nov 30, 2006
Est. expiryJan 28, 2017(expired)· nominal 20-yr term from priority
Inventors:David J. PowellConrad ChapmanKay MurphyTrudi Smith
A61P 35/00A61P 43/00A61K 38/00C12N 9/6478C12N 9/6413A61P 25/28C07K 14/4711A61K 48/00A61K 39/00
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.

Claims

exact text as granted — not AI-modified
1 - 9 . (canceled)  
     
     
         10 . An isolated ASP2 polypeptide comprising an amino acid sequence which is at least 90% identical to the amino acid sequence of SEQ ID NO:2 over its entire length.  
     
     
         11 - 19 . (canceled)

Join the waitlist — get patent alerts

Track US2006269539A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.